Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 AGTR1 💬 17件: Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
2 AGTR1 💬 17件: Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
3 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
4 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
5 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole sodium 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
6 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole magnesium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
7 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
8 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole magnesium 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
9 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole strontium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
10 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole sodium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
11 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
12 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
13 ATP4A 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
14 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
15 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole strontium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
16 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
17 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
18 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole sodium 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
19 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
20 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole sodium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
21 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
22 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Esomeprazole magnesium 💬 Esomeprazole 10件: 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
23 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
24 ATP4B 💬 3件: Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion Omeprazole magnesium 💬 Omeprazole 16件: 6, 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
25 CHRM1 💬 9件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases Bethanechol chloride 💬 Bethanechol 1件: 98 💬
26 CHRM2 💬 7件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton Bethanechol chloride 💬 Bethanechol 1件: 98 💬
27 CHRM3 💬 12件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases Bethanechol chloride 💬 Bethanechol 1件: 98 💬
28 CHRM4 💬 4件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton Bethanechol chloride 💬 Bethanechol 1件: 98 💬
29 CHRM5 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases Bethanechol chloride 💬 Bethanechol 1件: 98 💬
30 CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction Montelukast 💬 Montelukast 9件: 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
31 CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction Montelukast sodium 💬 Montelukast 9件: 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
32 FCER1A 💬 4件: Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
33 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
34 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
35 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
36 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
37 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
38 GABRA 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
39 GABRB 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
40 GABRB 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
41 GABRB 💬 7件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
42 GABRD 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
43 GABRE 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
44 GABRG 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
45 GABRG 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
46 GABRG 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
47 GABRP 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
48 GABRQ 💬 6件: Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction Propofol 💬 Propofol 10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
49 HRH1 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Inflammatory mediator regulation of TRP channels Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
50 HRH2 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Gastric acid secretion Famotidine 💬 Famotidine 7件: 6, 46, 61, 86, 98, 145, 300 💬
51 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
52 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
53 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
54 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
55 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron hydrochloride hydrate 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
56 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron hydrochloride hydrate 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
57 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron hydrochloride hydrate 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
58 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron hydrochloride hydrate 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
59 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
60 HTR3 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction Ondansetron hydrochloride hydrate 💬 Ondansetron 5件: 6, 97, 98, 107, 231 💬
61 IL13 💬 8件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, IL-17 signaling pathway, Th1 and Th2 cell differentiation, Fc epsilon RI signaling pathway, Pathways in cancer, Asthma, Inflammatory bowel disease Cendakimab 💬 Cendakimab 1件: 98 💬
62 IL4R 💬 8件: Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Inflammatory bowel disease Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
63 IL5 💬 13件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Pathways in cancer, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
64 IL5 💬 13件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Pathways in cancer, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection Reslizumab 💬 Reslizumab 2件: 44, 98 💬
65 IL5RA 💬 4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
66 KIT 💬 11件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
67 MTOR 💬 49件: ErbB signaling pathway, HIF-1 signaling pathway, Phospholipase D signaling pathway, Autophagy - other, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Apelin signaling pathway, Neutrophil extracellular trap formation, JAK-STAT signaling pathway, Th17 cell differentiation, Thermogenesis, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Growth hormone synthesis, secretion and action, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Pancreatic cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer, Choline metabolism in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Diabetic cardiomyopathy Sirolimus 💬 Sirolimus 46件: 2, 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
68 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Mometasone furoate hydrate 💬 Mometasone furoate 2件: 98, 162 💬
69 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Beclomethasone dipropionate 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
70 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Budesonide 💬 Budesonide 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
71 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Fluticasone 💬 Fluticasone 4件: 98, 228, 299, 306 💬
72 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Hydrocortisone 💬 Hydrocortisone 11件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 98, 299 💬
73 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Mometasone furoate 💬 Mometasone furoate 2件: 98, 162 💬
74 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Mometasone 💬 Mometasone 2件: 98, 162 💬
75 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Beclomethasone dipropionate monohydrate 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
76 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Beclometasone 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
77 NR3C1 💬 1件: Neuroactive ligand-receptor interaction Fluticasone propionate 💬 Fluticasone propionate 3件: 98, 228, 306 💬
78 S1PR1 💬 4件: FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Efferocytosis Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
79 S1PR1 💬 4件: FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Efferocytosis Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
80 S1PR4 💬 3件: FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
81 S1PR4 💬 3件: FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
82 S1PR5 💬 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
83 S1PR5 💬 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
84 SLC6A4 💬 3件: Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse Citalopram 💬 Citalopram 5件: 6, 13, 46, 98, 127 💬
85 SLC6A4 💬 3件: Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse Citalopram hydrobromide 💬 Citalopram 5件: 6, 13, 46, 98, 127 💬
86 TNF 💬 66件: MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
87 TSLP 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway Tezepelumab 💬 Tezepelumab 3件: 44, 45, 98 💬
88 TSLPR 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway Solrikitug 💬 Solrikitug 1件: 98 💬
89 VDR 💬 5件: Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation Cholecalciferol 💬 Cholecalciferol 23件: 6, 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬